Work

Pcn8 Comparing Patient-relevant Endpoint With Clinical Endpoint in a Rare Disease: the Case of Metastatic Merkel Cell Carcinoma Treated With Avelumab

Year: 2020

Type: article

Source: Value in Health

DOI: 10.1016/j.jval.2020.04.1515

Authors: M. Bharmal, S. Nolte, C. Lebbe, L. Mortier, A.S. Brohl, N. Fazio, J.J. Grob, S. Pusceddu, G.J. Hanna, J.C. Hassel, F. Kiecker, B. Ellers-Lenz, M. Bajars, G. Güzel, P. Nghiem, M. Hunger, M. Schlichting, M. Henry-Szatkowski, S.P. D'Angelo

Institutions: Hôpital Saint-Louis, Moffitt Cancer Center, European Institute of Oncology, Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille, Fondazione IRCCS Istituto Nazionale dei Tumori, Dana-Farber Cancer Institute, Heidelberg University, University Hospital Heidelberg, Merck KGaA, Darmstadt (Germany), EMD Serono, Inc. (United States), University of Washington, Merck Healthcare KGaA, Darmstadt (Germany), ICON PLC (Ireland), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Polyomavirus and related diseases

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3024367462

FWCI:

Cites:

Cited by:

Related to: 10